Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an incision to get a bone marrow sample -; or make a larger incision and remove a section of bone via surgery.

20 Apr 2018

Scientists develop tiny fluorescent probe that seeks out GLUT5 and detects cancer cells

Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology--a sugar-transporting biosensor--researchers at Michigan Technological University hope to reduce that timeframe down to minutes.

20 Apr 2018

Study: Inactivity of astronauts during spaceflights may have more pronounced effect on skeletal muscle than hypoxia

The inactivity of astronauts during spaceflights presents a significant risk to their muscles, says a new study in The Journal of Physiology. Scientists have simulated the impact of 21 day spaceflights on the body, and the impact of low gravity environments such as the Moon or Mars.

19 Apr 2018

Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens

Existing microscopy-based methods of detecting apoptosis, such as TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling), have limited quantitative capabilities due to insufficient signal-to-noise ratios.

19 Apr 2018

Physician assistants less likely to accurately diagnose early stage skin cancers

Physician assistants (PAs) are increasingly used in dermatology practices to cut costs and improve access to care, but are more likely than dermatologists to perform unnecessary skin biopsies to check for cancer, while being less likely to accurately diagnose early stage skin cancers, according to new research conducted by the University of Pittsburgh School of Medicine.

18 Apr 2018

Researchers evaluate accuracy of simple blood test to predict lung cancer

Every year, health care providers in the United States discover more than 1.6 million lung nodules in patients.

18 Apr 2018

Novel biomarker can distinguish between benign and malignant lung nodules

Researchers report a newly developed biomarker was 98% effective at distinguishing between benign and malignant lung nodules in a recent multicentre clinical trial.

18 Apr 2018

SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit

SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.

16 Apr 2018

Expedeon relocates to Cambridge as part of integration into SYGNIS Group

SYGNIS AG today announced the completion of the relocation of its subsidiary company, Expedeon, into the Company’s existing facilities in Cambridge, UK.

16 Apr 2018

'Molecular microscope' system for transplant biopsy more effective than conventional methods

A transplant biopsy system that uses gene chips to read molecules is far safer and more effective than existing approaches used for heart transplant biopsies and is showing promising results for lung transplant biopsies, new University of Alberta-led research shows.

13 Apr 2018

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

13 Apr 2018

New, sensitive HBV assay may allow earlier detection of hepatocellular carcinoma

Chronic hepatitis B virus (HBV) can progress to cirrhosis and hepatocellular carcinoma (HCC). A study published in The Journal of Molecular Diagnostics describes a new HBV assay that offers advantages over currently used methods because it has the capability to detect closed circular DNA (cccDNA) in serum, single cells, and preserved tissue samples.

12 Apr 2018

Study offers new hope for patients with intrahepatic cholangiocarcinoma

Kandice Fogle, 43, had just moved to Houston when she began experiencing pain in her back and groin. After undergoing a CT scan, doctors found a large mass in her liver. A biopsy confirmed that she had intrahepatic cholangiocarcinoma, more commonly known as bile duct cancer.

11 Apr 2018

Novel tool successfully predicts outcomes for lung cancer

Researchers have used open source data to develop a personalized risk assessment tool that can predict survival rate and treatment outcomes among patients with early-stage lung cancer.

11 Apr 2018

Scientists find new molecular target to treat idiopathic pulmonary fibrosis

Scientists searching for a therapy to stop the deadly and mostly untreatable lung disease, idiopathic pulmonary fibrosis (IPF), found a new molecular target that slows or stops the illness in preclinical laboratory tests.

10 Apr 2018

New microbiopsy device could revolutionize testing for skin cancer, other diseases

With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).

10 Apr 2018

Theresa May to launch £75m drive against prostate cancer

British Prime Minister Theresa May has declared war against prostate cancer. Yearly, 47,000 men are UK are diagnosed with this cancer and 11,000 succumb to it, according to reports. Recent reports show that prostate cancer in men kills more than breast cancer does in women.

10 Apr 2018

Prostate cancer on the rise and detected late in the UK finds report

As many as 37 percent of all prostate cancers are detected late or in advanced stages in the UK, finds a new report from the charity Orchid. The report suggests that most of these cancers are detected at stages 3 and 4. Statistics show that nearly 47,000 men are diagnosed with prostate cancer annually and 11,000 succumb to the disease each year.

9 Apr 2018

Researchers working to develop new system for early prostate cancer diagnosis

Researchers of the Universitat Politècnica de València and the Universidad de Granada, together with doctors from the Hospital Clínic Universitari de València are working on the development of a new system to help diagnose prostate cancer. The work being developed is part of the SICAP project.

3 Apr 2018

Cancers may be detected at smaller size in breasts with implants, study reveals

Breast augmentation with implants does not interfere with the ability to detect later breast cancers--in fact, cancers may be detected at a smaller size in breasts with implants, according to a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

29 Mar 2018

Biopsy News and Research

Further Reading

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

Scientists develop tiny fluorescent probe that seeks out GLUT5 and detects cancer cells

Study: Inactivity of astronauts during spaceflights may have more pronounced effect on skeletal muscle than hypoxia

Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens

Physician assistants less likely to accurately diagnose early stage skin cancers

Researchers evaluate accuracy of simple blood test to predict lung cancer

Novel biomarker can distinguish between benign and malignant lung nodules

SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit

Expedeon relocates to Cambridge as part of integration into SYGNIS Group

'Molecular microscope' system for transplant biopsy more effective than conventional methods

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

New, sensitive HBV assay may allow earlier detection of hepatocellular carcinoma

Study offers new hope for patients with intrahepatic cholangiocarcinoma

Novel tool successfully predicts outcomes for lung cancer

Scientists find new molecular target to treat idiopathic pulmonary fibrosis

New microbiopsy device could revolutionize testing for skin cancer, other diseases

Theresa May to launch £75m drive against prostate cancer

Prostate cancer on the rise and detected late in the UK finds report

Researchers working to develop new system for early prostate cancer diagnosis

Cancers may be detected at smaller size in breasts with implants, study reveals

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News